Advertisement

Topics

Ranbaxy Laboratories Ltd. Company Profile

11:01 EDT 27th June 2016 | BioPortfolio

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals, in developed and emerging markets many of which incorporate proprietary Novel Drug Delivery Systems (NDDS) and technologies, developed at its own labs. The company has further strengthened its focus on generics research and is increasingly working on more complex and specialty areas. Ranbaxy serves its customers in over 125 countries and has an expanding international portfolio of affiliates, joint ventures and alliances, ground operations in 46 countries and manufacturing operations in 7 countries. Ranbaxy is a member of the Daiichi Sankyo Group. Through strategic in-licensing opportunities and its hybrid business model with Daiichi Sankyo, a leading global pharma innovator headquartered in Tokyo, Japan, Ranbaxy is introducing many innovator products in markets around the world, where it has a strong presence. This is in line with the company’s commitment to increase penetration and improve access to medicines, across the globe. For more information, please visit www.ranbaxy.com.


News Articles [349 Associated News Articles listed on BioPortfolio]

Golden Week For Daiichi: Damages Due From Ranbaxy Brothers

In what seems like some consolation for Daiichi Sankyo after its disastrous acquisition of Ranbaxy Laboratories and subsequent divestment of the Indian company, arbitration proceedings in Singapore ag...

Sun's so-long wave to Tipperary: Indian firm to close Ranbaxy plant this year

Sun Pharmaceuticals has confirmed it will close a Ranbaxy Laboratories facility in Ireland by the end of the year.

Former Ranbaxy Owners Ordered to Pay $385M for Hiding FDA Probes

The two former owners of India's Ranbaxy Laboratories have been ordered to pay $385 million to Daiichi Sankyo Co., the Japanese pharmaceutical company that bought the drugmaker in 2008.

Japanese drugmaker Daiichi wins damages from former Ranbaxy owners

MUMBAI (Reuters) - The former owners of Indian drugmaker Ranbaxy Laboratories have been ordered by an arbitration court to pay damages worth 25.63 billion rupees ($385 million) to Japan's Daiichi Sank...

BRIEF-Daiichi Sankyo announces outcome of arbitration proceeding with Ranbaxy

* Says Daiichi Sankyo received a final award in the arbitration that it filed with the International Court of Arbitration of the International Chamber of Commerce in November 2012 against the former s...

Daiichi wins $400M in damages over Ranbaxy drug safety scandal

An arbitration panel found the former controlling stakeholders of Ranbaxy concealed information when they sold the firm to Daiichi Sankyo.

Sun Pharma Launches First OTC Drug

India’s Sun Pharmaceutical recently rolled out its first OTC drug, antacid Pepmelt, as it leverages the consumer healthcare portfolio acquired in its Ranbaxy Laboratories buy.

Concealed compliance info lands ex-Ranbaxy owners $385m costs

The former owners of Indian drugmaker Ranbaxy have been ordered to pay Daiichi Sankyo $385m for concealing quality problems across its manufacturing network before selling the business.

Drugs and Medications [431 Associated Drugs and Medications listed on BioPortfolio]

Desquam-x wash [Ranbaxy Laboratories Inc.]

DRUG FACTS

Famotidine [Ipca Laboratories Limited]

Famotidine Tablets USP

Cetirizine hydrochloride [Ipca Laboratories Limited]

Cetirizine Hydrochloride Tablets 10 mg

Clindamycin hydrochloride [RedPharm Drug Inc.]

Eurax [Ranbaxy Laboratories Inc.]

Eurax (crotamiton USP)Lotion/Cream (10% w/w)FOR TOPICAL USE ONLYNOT FOR OPHTHALMIC, ORAL, OR INTRAVAGINAL USERx only

PubMed Articles [179 Associated PubMed Articles listed on BioPortfolio]

A multilaboratory study on the variability of bovine semen analysis.

To evaluate the variability of semen analysis, five replicates of 10 different bovine frozen semen batches were coded with different identification numbers and submitted to various laboratories for ev...

Mobile electrodiagnostic laboratories provide substandard patient care.

Mobile electrodiagnostic (EDX) laboratories often do not appear to comply with Medicare rules or the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) standards.

Pharmacology Portal: An Open Database for Clinical Pharmacologic Laboratory Services.

More than 50 Norwegian public and private laboratories provide one or more analyses for therapeutic drug monitoring or testing for drugs of abuse. Practices differ among laboratories, and analytical r...

Comparability study of analytical results between a group of clinical laboratories.

To describe the study of the comparability of the measurements levels of biological tests processed in biochemistry in Catlab's 4 laboratories.

Giving your heart to pathology.

Jim KIaassen recently joined Axiom Veterinary Laboratories as a clinical pathologist. During his career, Dr Klaassen has worked in small animal practice, lectured in clinical pathology, undertaken pre...

Clinical Trials [215 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

To compare the single-dose oral bioavailability of clarithromycin 250-mg/5 mL powder for oral suspension of Ranbaxy Laboratories with that of Abbott Laboratories (Biaxin®) following admin...

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

This open-label, balanced, randomized, two-treatment, four-period, two-sequence, single dose, crossover fully replicated study was conducted on fixed-dose combination of quinapril 20 mg an...

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fed Conditions

The objective of this study was to compare the single-dose oral bioavailability of Carvedilol 12.5 mg tablets of Ranbaxy Laboratories with Coreg 12.5 mg tablets of Glaxosmithkline in healt...

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions

The objective of this study is to compare the relative bioavailability of glimepiride 1 mg tablets (manufactured by Ranbaxy Laboratories Limited) with that of AMARYL® 1 mg tablets (follow...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet ...

Companies [921 Associated Companies listed on BioPortfolio]

Ranbaxy Pharmaceuticals Inc.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida USA, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India’s largest pharmaceutical comp...

Ranbaxy Laboratories Ltd.

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, aff...

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, headquartered in India, is an integrated, research based, international pharmaceutical company, producing a wide range of quality,...

Sterling Rasayan (P) Ltd

In less than twenty years, Sterling through its professional approach and innovative marketing strategy has been able to cater to the requirements of many prestigious customers from local producers t...

KENT LABORATORIES

Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

More Information about "Ranbaxy Laboratories Ltd." on BioPortfolio

We have published hundreds of Ranbaxy Laboratories Ltd. news stories on BioPortfolio along with dozens of Ranbaxy Laboratories Ltd. Clinical Trials and PubMed Articles about Ranbaxy Laboratories Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ranbaxy Laboratories Ltd. Companies in our database. You can also find out about relevant Ranbaxy Laboratories Ltd. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record